Plain-English translation of NCT07517302 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding the Kahook Dual Blade goniotomy—a minimally invasive technique that removes a small part of the eye's drainage system—helps lower eye pressure better when combined with standard cataract and glaucoma surgery. Right now, standard surgery alone doesn't always control eye pressure well enough in people with chronic angle-closure glaucoma. The new treatment aims to improve pressure control with fewer complications.
Chronic angle-closure glaucoma causes the eye's drainage system to close over time, leading to dangerously high eye pressure that can damage vision permanently. While standard surgery (cataract removal and angle opening) helps, many patients still need additional eye pressure medication or more surgery. This trial exists to see if the new minimally invasive technique can prevent that and give patients better, longer-lasting pressure control.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either standard cataract and glaucoma surgery alone, or the same surgery plus the new Kahook Dual Blade technique. The surgery happens once, but you will have follow-up visits over 1 year so the research team can measure your eye pressure, check for any complications, and see how well each approach works. Throughout the year, your eye pressure and vision will be monitored carefully to track your progress.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China